Patents by Inventor Ben Feringa

Ben Feringa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080275274
    Abstract: Process for the preparation of enantiomerically enriched compounds of formula Ar—C(R1)—C(R2)-Z wherein Ar represents an optionally substituted (hetero)aryl group R1 and R2, each independently, represent H, an alkyl, (hetero)aryl, dialkylamino, amido, thioether, alkoxy or aryloxy group with the proviso that not both R1 and R2 represent H, or R1 and R2 form together with the C-atoms to which they are bound a (hetero)alkyl or (hetero)alkenyl ring and Z represents an electron withdrawing group, in which process a boronic acid derivate of formula Ar—B(OR3)OR4 or its anhydride, wherein R3 and R4, each independently, represent H or an alkyl group, is reacted with an olefinic unsaturated compound of formula R2—C?C—(R1)Z in the presence of a transition metal catalyst comprising a transition metal chosen from Cu and group VIII and an enantiomerically enriched ligand L, having formula (I) where Cn together with the two O-atoms and the P-atom forms a substituted or nonsubstituted ring with 2-6 C-atoms, R5 and R6 each ind
    Type: Application
    Filed: May 2, 2008
    Publication date: November 6, 2008
    Applicant: DSM IP ASSETS B.V.
    Inventors: Adriaan Jacobus MINNAARD, Ben FERINGA, Rosalinde IMBOS, Jean-Guy France BOITEAU
  • Patent number: 6989461
    Abstract: Catalyst for the asymmetric (transfer) hydrogenation represented by the formula MLaXbSc, where M is a transition metal, to be chosen from rhodium and ruthenium, and X is a counter ion and S is a ligand, a ranges from 0.5 to 3 and b and c, each independently, range from 0 to 2, and L is a chiral ligand having the formula (1), where Cn together with the two 2 O-atoms and the P-atom forms a substituted or non-substituted ring with 2-4 C-atoms, R1 and R2 each independently represent H, an optionally substituted alkyl, aryl, alkaryl or aralkyl group or may form a (heterocyclic) ring together with the N-atom to which they are bound. And a process for the asymmetric (transfer) hydrogenation of an olefinically unsaturated compound, ketone, imine or oxime derivate in the presence of a hydrogen donor and of a catalyst, use being made of a catalyst represented by formula MLaXbSc, where M is a transition metal, to be chosen from rhodium, iridium and ruthenium, X is a counter ion, S is a ligand, a ranges from 0.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: January 24, 2006
    Assignee: DSM IP Assets B.V.
    Inventors: Michel Berg Van Den, Ben Feringa, Adriaan Jacobus Minnaard, Johannes Gerardus Vries De
  • Publication number: 20050245756
    Abstract: Process for the preparation of enantiomerically enriched compounds with Formula Ar—C(R1)—C(R2)-Z wherein Ar represents an optionally substituted (hetero)aryl group, R1 and R2, each independently, represent H, an alkyl, (hetero)aryl, dialky-lamino, amido, thioether, alkoxy or aryloxy group with the proviso that not both R1 and R2 represent H, or R1 and R2 form together with the C-atoms to which they are bound a (hetero)alkyl or (hetero) alkenyl ring and Z represents an electron withdrawing group, in which process a boronic acid derivate of Formula Ar—B(OR3)OR4 or its anhydride, wherein Ar is as described above and R3 and R4, each independently, represent H or an alkyl group, is reacted with an olefinic unsaturated compound with Formula R2—C?C—(R1)Z, wherein R1, R2 and Z are as described above, in the presence of a transition metal catalyst comprising a transition metal chosen from Cu and group VIII of the Periodic Table and an enantiomerically enriched ligand L, having the Formula (I) where Cn together with th
    Type: Application
    Filed: March 20, 2003
    Publication date: November 3, 2005
    Inventors: Adriaan Minnaard, Ben Feringa, Rosalinde Imbos, Jean-Guy Boiteau
  • Publication number: 20030199713
    Abstract: Catalyst for the asymmetric (transfer) hydrogenation represented by the formula MLaXbSc, where M is a transition metal, to be chosen from rhodium and ruthenium, and X is a counter ion and S is a ligand, a ranges from 0.5 to 3 and b and c, each independently, range from 0 to 2, and L is a chiral ligand having the formula (1), where Cn together with the two 2 O-atoms and the P-atom forms a substituted or non-substituted ring with 2-4 C-atoms, R1 and R2 each independently represent H, an optionally substituted alkyl, aryl, alkaryl or aralkyl group or may form a (heterocyclic) ring together with the N-atom to which they are bound. And a process for the asymmetric (transfer) hydrogenation of an olefinically unsaturated compound, ketone, imine or oxime derivate in the presence of a hydrogen donor and of a catalyst, use being made of a catalyst represented by formula MLaXbSc, where M is a transition metal, to be chosen from rhodium, iridium and ruthenium, X is a counter ion, S is a ligand, a ranges from 0.
    Type: Application
    Filed: January 7, 2003
    Publication date: October 23, 2003
    Inventors: Michel Berg Van Den, Ben Feringa, Adriaan Jacobus Minnaard, Johannes Gerardus Vries De